170 related articles for article (PubMed ID: 36482913)
21. Takayasu arteritis and giant cell arteritis: a spectrum within the same disease?
Maksimowicz-McKinnon K; Clark TM; Hoffman GS
Medicine (Baltimore); 2009 Jul; 88(4):221-226. PubMed ID: 19593227
[TBL] [Abstract][Full Text] [Related]
22. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography.
Prieto-González S; Arguis P; García-Martínez A; Espígol-Frigolé G; Tavera-Bahillo I; Butjosa M; Sánchez M; Hernández-Rodríguez J; Grau JM; Cid MC
Ann Rheum Dis; 2012 Jul; 71(7):1170-6. PubMed ID: 22267328
[TBL] [Abstract][Full Text] [Related]
23. Large-vessel involvement is predictive of multiple relapses in giant cell arteritis.
de Mornac D; Espitia O; Néel A; Connault J; Masseau A; Espitia-Thibault A; Artifoni M; Achille A; Wahbi A; Lacou M; Durant C; Pottier P; Perrin F; Graveleau J; Hamidou M; Hardouin JB; Agard C
Ther Adv Musculoskelet Dis; 2021; 13():1759720X211009029. PubMed ID: 34046092
[TBL] [Abstract][Full Text] [Related]
24. The Immunopathology of Giant Cell Arteritis Across Disease Spectra.
Robinette ML; Rao DA; Monach PA
Front Immunol; 2021; 12():623716. PubMed ID: 33717128
[TBL] [Abstract][Full Text] [Related]
25. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
26. Extra-cranial giant cell arteritis and Takayasu arteritis: How similar are they?
Kermani TA; Crowson CS; Muratore F; Schmidt J; Matteson EL; Warrington KJ
Semin Arthritis Rheum; 2015 Jun; 44(6):724-8. PubMed ID: 25712813
[TBL] [Abstract][Full Text] [Related]
27. Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy.
Grossman C; Barshack I; Koren-Morag N; Ben-Zvi I; Bornstein G
Clin Rheumatol; 2016 Jul; 35(7):1817-22. PubMed ID: 26925851
[TBL] [Abstract][Full Text] [Related]
28. The incidence of giant cell arteritis in Slovenia.
Pucelj NP; Hočevar A; Ješe R; Rotar Ž; Hawlina M; Fakin A; Pižem J; Tomšič M
Clin Rheumatol; 2019 Feb; 38(2):285-290. PubMed ID: 30062445
[TBL] [Abstract][Full Text] [Related]
29. Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis.
Kermani TA; Warrington KJ; Crowson CS; Ytterberg SR; Hunder GG; Gabriel SE; Matteson EL
Ann Rheum Dis; 2013 Dec; 72(12):1989-94. PubMed ID: 23253927
[TBL] [Abstract][Full Text] [Related]
30. Symptomatic lower extremity vasculitis in giant cell arteritis: a case series.
Kermani TA; Matteson EL; Hunder GG; Warrington KJ
J Rheumatol; 2009 Oct; 36(10):2277-83. PubMed ID: 19755612
[TBL] [Abstract][Full Text] [Related]
31. Incidence of giant cell arteritis in six districts of Paris, France (2015-2017).
Gonzalez Chiappe S; Lechtman S; Maldini CS; Mekinian A; Papo T; Sené T; Mahr AD
Rheumatol Int; 2022 Oct; 42(10):1721-1728. PubMed ID: 35819504
[TBL] [Abstract][Full Text] [Related]
32. The different clinical patterns of giant cell arteritis.
de Boysson H; Liozon E; Ly KH; Dumont A; Delmas C; Aouba A
Clin Exp Rheumatol; 2019; 37 Suppl 117(2):57-60. PubMed ID: 31162029
[TBL] [Abstract][Full Text] [Related]
33. Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions.
Aschwanden M; Kesten F; Stern M; Thalhammer C; Walker UA; Tyndall A; Jaeger KA; Hess C; Daikeler T
Ann Rheum Dis; 2010 Jul; 69(7):1356-9. PubMed ID: 20498213
[TBL] [Abstract][Full Text] [Related]
34. Prognosis of large vessel involvement in large vessel vasculitis.
Vautier M; Dupont A; de Boysson H; Comarmond C; Mirault T; Mekinian A; Lambert M; Ferfar Y; Aouba A; Cacoub P; Resche-Rigon M; Saadoun D
J Autoimmun; 2020 Mar; 108():102419. PubMed ID: 32035747
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis: a series of 36 patients.
Assie C; Janvresse A; Plissonnier D; Levesque H; Marie I
Medicine (Baltimore); 2011 Jan; 90(1):40-51. PubMed ID: 21200185
[TBL] [Abstract][Full Text] [Related]
36. Incidence of biopsy-proven giant cell arteritis (GCA) in South Australia 2014-2020.
Ninan J; Ruediger C; Dyer KA; Dodd T; Black RJ; Lyne S; Shanahan EM; Proudman SM; Lester S; McNeil J; Hill CL
Front Med (Lausanne); 2023; 10():1173256. PubMed ID: 37153092
[TBL] [Abstract][Full Text] [Related]
37. The presence of both HLA-DRB1*04:01 and HLA-B*15:01 increases the susceptibility to cranial and extracranial giant cell arteritis.
Prieto-Peña D; Remuzgo-Martínez S; Ocejo-Vinyals JG; Atienza-Mateo B; Genre F; Muñoz-Jimenez A; Ortiz-Sanjuán F; Romero-Yuste S; Moriano C; Galindez-Agirregoikoa E; Calvo I; Ortego-Centeno N; Álvarez-Rivas N; Miranda-Filloy JA; Llorente I; García-García J; Blanco R; Gualillo O; Martin J; Castañeda S; Lopez-Mejías R; González-Gay MA
Clin Exp Rheumatol; 2021; 39 Suppl 129(2):21-26. PubMed ID: 33734973
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and differential diagnosis of large-vessel vasculitides.
Keser G; Aksu K
Rheumatol Int; 2019 Feb; 39(2):169-185. PubMed ID: 30221327
[TBL] [Abstract][Full Text] [Related]
39. Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measure.
Robson JC; Almeida C; Dawson J; Bromhead A; Dures E; Guly C; Hoon E; Mackie S; Ndosi M; Pauling J; Hill C
Rheumatology (Oxford); 2021 Oct; 60(10):4671-4680. PubMed ID: 33528002
[TBL] [Abstract][Full Text] [Related]
40. A cohort study reveals myocarditis to be a rare and life-threatening presentation of large vessel vasculitis.
Bechman K; Gopalan D; Nihoyannopoulos P; Mason JC
Semin Arthritis Rheum; 2017 Oct; 47(2):241-246. PubMed ID: 28502640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
